The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| ICUI | -31.53% | -36.89% | -8.79% | +2,553% |
| S&P | +16.23% | +94.45% | +14.22% | +1,569% |
ICU Medical, Inc. engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. Its product portfolio includes intravenous smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle-free connectors. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA.
A leading manufacturer of intravenous therapy solutions is about to get a lot bigger.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $548.70M | -7.9% |
| Gross Profit | $208.29M | 1.2% |
| Gross Margin | 37.96% | 3.4% |
| Market Cap | $3.25B | 12.4% |
| Market Cap / Employee | $0.22M | 0.0% |
| Employees | 15K | 7.1% |
| Net Income | $35.34M | 265.1% |
| EBITDA | $76.70M | -1.8% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $300.03M | -0.9% |
| Accounts Receivable | $179.50M | 18.3% |
| Inventory | 616.5 | -9.7% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $1.39B | -13.6% |
| Short Term Debt | $14.74M | -78.9% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -0.88% | 0.7% |
| Return On Invested Capital | 1.16% | -2.1% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$8.49M | -113.6% |
| Operating Free Cash Flow | $11.21M | -86.3% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 2.18 | 1.85 | 1.73 | 1.64 | 16.94% |
| Price to Sales | 1.90 | 1.60 | 1.41 | 1.38 | 9.49% |
| Price to Tangible Book Value | -20.68 | -17.61 | -16.34 | -17.67 | 39.49% |
| Price to Free Cash Flow TTM | 26.21 | 30.49 | 25.91 | 53.95 | 211.77% |
| Enterprise Value to EBITDA | 75.44 | 53.18 | 59.49 | 56.98 | 4.15% |
| Free Cash Flow Yield | 3.8% | 3.3% | 3.9% | 1.9% | -67.93% |
| Return on Equity | -5.4% | -5.8% | -4.6% | -1.8% | -47.81% |
| Total Debt | $1.66B | $1.64B | $1.60B | $1.40B | -16.34% |
ICUI earnings call for the period ending September 30, 2021.
ICUI earnings call for the period ending June 30, 2021.
ICUI earnings call for the period ending April 30, 2021.
ICUI earnings call for the period ending December 31, 2020.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
